Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Feb 01, 2023

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
PLBY Grp Inc	Suhail R. Rizvi	Director, Ten Percent Owner		01 Feb 2023	11,021,569	21,765,783	-		0	Common Stock
PLBY Grp Inc	Suhail R. Rizvi	Director, Ten Percent Owner		01 Feb 2023	10,739,714	0	-		-	Subscription Rights (rights to buy)
Advantage Soln Inc (Class A)	David A. Peacock	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	3,250,000	3,250,000	-		-	Stock Option (right to Buy)
Advantage Soln Inc (Class A)	David A. Peacock	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	2,750,000	2,750,000	-		-	Stock Option (right to Buy)
Advantage Soln Inc (Class A)	David A. Peacock	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	2,000,000	2,000,000	-		-	Stock Option (right to Buy)
Advantage Soln Inc (Class A)	David A. Peacock	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	1,698,112	1,698,112	-		0	Class A Common Stock
Erasca Inc	Jonathan E. Lim	Director, Chairman & CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	1,500,000	1,500,000	-		-	Stock Option (right to buy)
Advanced Emissions Soln Inc	Julian McIntyre	Director	Purchase of securities on an exchange or from another person at price $ 4.00 per share.	01 Feb 2023	1,197,124	1,197,124 (6%)	6%	4	4,788,496	Common Stock
Arbutus Biopharma Corp	William H. Collier	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	866,000	866,000	-		-	Stock Option (Right to Buy)
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	813,600	813,600	-		-	Stock Option (Right to Buy)
PLBY Grp Inc	Bernhard Kohn	Director, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	799,684	0	-		-	Subscription Right
Peloton Interactive Inc	Leslie Berland	Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	778,547	778,547	-		-	Restricted Stock Unit (RSU)
Riot Platforms Inc	Chad Everett Harris	(SEE REMARKS)	Sale or transfer of securities back to the company at price $ 0.00 per share.	01 Feb 2023	742,942	232,400 (0%)	2%		0	Common Stock
Advanced Emissions Soln Inc	Jeremy Blank	Director	Purchase of securities on an exchange or from another person at price $ 4.00 per share.	01 Feb 2023	631,866	631,866 (3%)	3%	4	2,527,464	Common Stock
Senti Biosciences Inc Board Meeting	Timothy Lu	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	630,000	630,000	-		-	Stock Option (Right to Buy)
Erasca Inc	David M. Chacko	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	600,000	600,000	-		-	Stock Option (right to buy)
Quince Therapeutics Inc	Dirk Thye	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	600,000	600,000	-		-	Employee Stock Option (right to buy)
Apartment Investment & Management Co. (Class A)	Terry Considine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	568,422	2,307,241	-		-	LTIP II Units of Aimco OP L.P.
Erasca Inc	Wei Lin	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	560,000	560,000	-		-	Stock Option (right to buy)
Olema Pharma Inc	Sean Bohen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	550,000	550,000	-		-	Stock Option (Right to Buy)
Spero Therapeutics Inc	Ankit Mahadevia	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	531,914	810,118 (4%)	2%		0	Common Stock
Carrier Global Dividend	David L. Gitlin	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	506,360	506,360	-		-	Stock Appreciation Right
Taboola.com Ltd	Eldad Maniv	President and COO	Sale of securities on an exchange or to another person at price $ 4.06 per share.	01 Feb 2023	505,930	8,575,378	-	4.1	2,054,076	Ordinary Shares
Erasca Inc	Ebun S. Garner	General Counsel & Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	480,000	480,000	-		-	Stock Option (right to buy)
Recursion Pharma Inc (Class A)	Tina Marriott Larson	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	434,122	434,122	-		-	Stock Option (Right to Buy)
PLBY Grp Inc	Bernhard Kohn	Director, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share.	01 Feb 2023	426,994	445,309	-	2.6	1,091,439	Common Stock
Apartment Investment & Management Co. (Class A)	Terry Considine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	416,241	1,738,819	-		-	LTIP II Units of Aimco OP L.P.
Design Therapeutics Inc	Joao Siffert	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	415,000	415,000	-		-	Stock Option (right to buy)
Design Therapeutics Inc	Pratik Shah	Director, Executive Chairperson	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	415,000	415,000	-		-	Stock Option (right to buy)
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	406,800	932,605	-		0	Class A Common Stock
Recursion Pharma Inc (Class A)	Michael Secora	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	404,857	404,857	-		-	Stock Option (Right to Buy)
ORIC Pharma Inc	Jacob M. Chacko	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	400,000	400,000	-		-	Stock Option (right to buy)
Aclaris Therapeutics Inc	Douglas J. Manion	Director, Pres and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	378,000	378,000	-		-	Employee Stock Option (Right to Buy)
Zentalis Pharma Inc High Gain High Volume	Kimberly Blackwell	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	355,200	355,200	-		-	Stock Option (Right to Buy)
ADT Inc	Thorsen Wayne	EVP, Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	341,296	341,296 (0%)	0%		0	Common Stock
Bakkt Holdings Inc (Class A)	Gavin Michael	Director, CEO and President	Sale of securities on an exchange or to another person at price $ 1.59 per share.	01 Feb 2023	340,002	2,446,547	-	1.6	540,739	Class A Common Stock
Arbutus Biopharma Corp	Michael J. McElhaugh	Chief Business Officer		01 Feb 2023	334,700	334,700	-		-	Stock Option (Right to Buy)
Arbutus Biopharma Corp	Michael J. Sofia	Chief Scientific Officer		01 Feb 2023	328,700	328,700	-		-	Stock Option (Right to Buy)
Alphatec Holdings Inc	Patrick S Miles	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	316,311	5,617,944 (9%)	0%		0	Common Stock
Arbutus Biopharma Corp	David C. Hastings	Chief Financial Officer		01 Feb 2023	316,000	316,000	-		-	Stock Option (Right to Buy)
Bakkt Holdings Inc (Class A)	Gavin Michael	Director, CEO and President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share.	01 Feb 2023	307,580	2,138,967	-	2	615,160	Class A Common Stock
Caredx Inc	Reginald Seeto	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	302,000	569,152 (1%)	0%		0	Common Stock
Eledon Pharma Inc	David-Alexandre C. Gros	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	300,000	300,000	-		-	Stock Option (right to buy)
Frequency Therapeutics Inc	David L. Lucchino	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	300,000	723,421 (2%)	0%		-	Common Stock
Frequency Therapeutics Inc	David L. Lucchino	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	300,000	0	-		-	Restricted Stock Units
Taboola.com Ltd	Eldad Maniv	President and COO	Sale of securities on an exchange or to another person at price $ 4.25 per share.	01 Feb 2023	294,070	8,281,308	-	4.3	1,249,798	Ordinary Shares
Arbutus Biopharma Corp	Elizabeth Howard	EVP, GC, Compliance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	278,700	278,700	-		-	Stock Option (Right to Buy)
Spero Therapeutics Inc	Tamara L. Joseph	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	265,957	328,038 (1%)	1%		0	Common Stock
Spero Therapeutics Inc	Timothy Keutzer	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	265,957	330,538 (1%)	1%		0	Common Stock
Spero Therapeutics Inc	Sath Shukla	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	265,957	322,021 (1%)	1%		0	Common Stock
Spero Therapeutics Inc	Kamal Hamed	Chief Medical Officer		01 Feb 2023	265,957	475,957 (2%)	1%		0	Common Stock
ProPetro Holding Corp	Phillip Anthony Gobe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	252,393	368,644 (0%)	0%		0	Common Stock
Zentalis Pharma Inc High Gain High Volume	Kimberly Blackwell	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	244,800	249,800	-		0	Common Stock
Rallybio Corp Board Meeting	Jonathan I. Lieber	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	240,000	240,000	-		-	Option (Right to Buy)
Zentalis Pharma Inc High Gain High Volume	Cam S. Gallagher	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	233,908	233,908	-		-	Stock Option (Right to Buy)
Rhythm Pharma Inc	David P. Meeker	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	229,600	229,600	-		-	Stock Option (Right to Buy)
Fortinet	Michael Xie	Director, VP, Engineering & CTO	Sale of securities on an exchange or to another person at price $ 53.70 per share.	01 Feb 2023	227,372	29,739,692 (17%)	0%	53.7	12,209,035	Common Stock
Carrier Global Dividend	Patrick P. Goris	Senior Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	227,070	227,070	-		-	Stock Appreciation Right
Carrier Global Dividend	Christopher Nelson	President, HVAC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	227,070	227,070	-		-	Stock Appreciation Right
Quince Therapeutics Inc	Karen L. Smith	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	225,000	225,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	Brendan Hannah	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	225,000	225,000	-		-	Employee Stock Option (right to buy)
Fortinet	Michael Xie	Director, VP, Engineering & CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	225,000	0	-		-	Nonqualified Stock Option (right to buy)
Fortinet	Michael Xie	Director, VP, Engineering & CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.76 per share.	01 Feb 2023	225,000	29,967,064 (17%)	0%	4.8	1,071,000	Common Stock
Monopar Therapeutics Inc	Chandler D. Robinson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	221,839	221,839	-		-	Stock Options
PLBY Grp Inc	Lance Barton	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	221,065	0	-		-	Subscription Right
Riot Platforms Inc	Chad Everett Harris	(SEE REMARKS)	Sale or transfer of securities back to the company at price $ 0.00 per share.	01 Feb 2023	218,000	14,400 (0%)	0%		0	Common Stock
Recursion Pharma Inc (Class A)	Tina Marriott Larson	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	217,061	422,808	-		0	Class A Common Stock
Arbutus Biopharma Corp	William H. Collier	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	216,500	216,500 (0%)	0%		0	Common Shares
Carlyle Grp Inc	Bruce M. Larson	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	214,128	403,840 (0%)	0%		0	Common Stock
Recursion Pharma Inc (Class A)	Shafique Virani	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	212,507	212,507	-		-	Stock Option (Right to Buy)
Hormel Foods	James P. Snee	Director, CHAIRMAN, PRESIDENT AND CEO		01 Feb 2023	208,100	208,100	-		-	Stock Options (Right to Buy)
Alphatec Holdings Inc	Patrick S Miles	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	206,782	5,824,726 (9%)	0%		0	Common Stock
Recursion Pharma Inc (Class A)	Michael Secora	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	202,428	790,502	-		0	Class A Common Stock
LoanDepot Inc (Class A)	John Hoon Lee	Director	Sale of securities on an exchange or to another person at price $ 2.56 per share.	01 Feb 2023	200,000	684,108 (1%)	0%	2.6	512,960	Class A Common Stock
Olema Pharma Inc	Shane Kovacs	Ch. Operating & Financial Off.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	200,000	200,000	-		-	Stock Option (Right to Buy)
Village Farms Intl Inc	Ann Gillin Lefever	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	200,000	200,000	-		-	Options
Senti Biosciences Inc Board Meeting	Philip Lee	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	195,000	195,000	-		-	Stock Option (Right to Buy)
GE HealthCare Tech Partnership	Peter J. Arduini	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	188,127	188,127	-		-	Employee Stock Option (right to buy)
Freshworks Inc (Class A)	Rathna Girish Mathrubootham	Director, Chief Executive Officer		01 Feb 2023	187,500	16,387,991	-		-	Class B Common Stock
Freshworks Inc (Class A)	Rathna Girish Mathrubootham	Director, Chief Executive Officer		01 Feb 2023	187,500	2,062,500	-		-	Restricted Stock Units
Carrier Global Dividend	Jurgen Timperman	President, Fire & Security	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	181,655	181,655	-		-	Stock Appreciation Right
Quantum Corp	Kenneth P. Gianella	Chief Financial Officer		01 Feb 2023	175,000	175,000 (0%)	0%		0	Common Stock
ProPetro Holding Corp	Samuel D. Sledge	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	174,358	341,407	-		-	Restricted Stock Units
Monopar Therapeutics Inc	Chandler D. Robinson	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	169,012	326,907	-		-	Restricted Stock Units
Zentalis Pharma Inc High Gain High Volume	Cam S. Gallagher	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	161,092	513,103	-		0	Common Stock
Bluejay Diagnostics Inc	Neil Dey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	159,090	606,150	-	0.4	70,000	Common Stock
Carlyle Grp Inc	Jeffrey W. Ferguson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	158,510	1,187,246 (0%)	0%		0	Common Stock
Caredx Inc	Reginald Seeto	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	156,000	156,000	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Paul Sean Little	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	155,000	155,000	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Bryan E. Smith	General Counsel, Corporate Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	155,000	155,000	-		-	Stock Option (right to buy)
Eledon Pharma Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	155,000	155,000	-		-	Stock Option (right to buy)
Eledon Pharma Inc	David-Alexandre C. Gros	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	153,600	153,600	-		-	Stock Option (right to buy)
Olema Pharma Inc	John B. Moriarty	EVP, Ch. Legal Officer & Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Olema Pharma Inc	Cyrus L. Harmon	Director, Chief Research Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Olema Pharma Inc	David C. Myles	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Olema Pharma Inc	Kinney Horn	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Olema Pharma Inc	Naseem Zojwalla	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Zentalis Pharma Inc High Gain High Volume	Melissa B. Epperly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	148,043	148,043	-		-	Stock Option (Right to Buy)
Alphatec Holdings Inc	Craig E. Hunsaker	EVP, PEOPLE/CULTURE & GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	146,297	1,357,471 (2%)	0%		0	Common Stock
Annaly Cap Management Inc Results Board Meeting	David L. Finkelstein	Director, CEO and CIO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	145,500	522,249 (0%)	0%		0	Common Stock
ORIC Pharma Inc	Pratik S. Multani	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	145,000	145,000	-		-	Stock Option (right to buy)
ORIC Pharma Inc	Dominic G. Piscitelli	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	145,000	145,000	-		-	Stock Option (right to buy)
Design Therapeutics Inc	Sean Jeffries	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	140,000	140,000	-		-	Stock Option (right to buy)
Carlyle Grp Inc	Curtis L. Buser	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	139,971	1,234,455 (0%)	0%		0	Common Stock
Carlyle Grp Inc	Christopher Finn	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	139,971	971,921 (0%)	0%		0	Common Stock
Ares Management Corp (Class A)	Antony P. Ressler	Director, Co-Founder & Exec. Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 85.33 per share.	01 Feb 2023	138,332	574,338 (0%)	0%	85.3	11,803,870	Class A Common Stock
Zentalis Pharma Inc High Gain High Volume	Kevin D. Bunker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	132,646	132,646	-		-	Stock Option (Right to Buy)
Senti Biosciences Inc Board Meeting	Kanya Rajangam	Chief Medical & Devt. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	130,000	130,000	-		-	Stock Option (Right to Buy)
Senti Biosciences Inc Board Meeting	Deborah Knobelman	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	130,000	130,000	-		-	Stock Option (Right to Buy)
Surrozen Inc Board Meeting	Wen-Chen Yeh	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	125,000	125,000	-		-	Option (right to buy)
Charles Schwab Board Meeting	Charles R. Schwab	Director, Co-Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.40 per share.	01 Feb 2023	121,066	0 (0%)	0%	16.4	1,985,482	Common Stock
Charles Schwab Board Meeting	Charles R. Schwab	Director, Co-Chairman	Sale of securities on an exchange or to another person at price $ 77.84 per share.	01 Feb 2023	121,066	60,223,399 (4%)	0%	77.8	9,424,153	Common Stock
Charles Schwab Board Meeting	Charles R. Schwab	Director, Co-Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	121,066	0	-		-	Nonqualified Stock Option (right to buy)
Samsara Inc (Class A) Board Meeting	Benjamin Calderon	See remarks		01 Feb 2023	120,000	698,315	-		0	Class A Common Stock
Samsara Inc (Class A) Board Meeting	Benjamin Calderon	See remarks		01 Feb 2023	120,000	8,811,564	-		-	Class B Common Stock
Samsara Inc (Class A) Board Meeting	Benjamin Calderon	See remarks	Sale of securities on an exchange or to another person at price $ 13.92 per share.	01 Feb 2023	120,000	578,315	-	13.9	1,670,316	Class A Common Stock
Apartment Investment & Management Co. (Class A)	Robert A. Miller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	116,960	228,803	-		-	Stock Option (right to buy)
Apartment Investment & Management Co. (Class A)	Terry Considine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	116,960	2,424,201	-		-	LTIP II Units of Aimco OP L.P.
Bluejay Diagnostics Inc	Kenneth R. Fisher	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	112,500	152,500	-	0.4	49,500	Common Stock
Black Stone Minerals L.P. - Unit	Thomas L. Carter	Director, CEO and Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	110,295	2,468,347 (1%)	0%		0	Common units representing limited partner interests
Evolent Health Inc (Class A)	Frank J. Williams	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	110,000	9,060	-		-	Class A Common Stock Option (right to buy)
Evolent Health Inc (Class A)	Frank J. Williams	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share.	01 Feb 2023	110,000	736,479 (0%)	0%	3.8	422,400	Class A Common Stock
Quince Therapeutics Inc	Ted Monohon	Chief Accounting Officer & VP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	110,000	110,000	-		-	Employee Stock Option (right to buy)
Evolent Health Inc (Class A)	Frank J. Williams	Director	Sale of securities on an exchange or to another person at price $ 32.15 per share.	01 Feb 2023	108,500	627,979 (0%)	0%	32.2	3,488,275	Class A Common Stock
Aclaris Therapeutics Inc	Douglas J. Manion	Director, Pres and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	108,000	108,000	-		-	Restricted Stock Units
Recursion Pharma Inc (Class A)	Shafique Virani	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	106,253	182,003	-		0	Class A Common Stock
Corporate Office Properties Trust	Stephen E. Budorick	PRESIDENT /CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	105,546	392,330	-		-	Profit Interest Units
Aclaris Therapeutics Inc	Gail Cawkwell	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	105,000	105,000	-		-	Employee Stock Option (Right to Buy)
Aclaris Therapeutics Inc	James Loerop	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	105,000	105,000	-		-	Employee Stock Option (Right to Buy)
Aclaris Therapeutics Inc	Joseph Monahan	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	105,000	105,000	-		-	Employee Stock Option (Right to Buy)
Aclaris Therapeutics Inc	Kevin Balthaser	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	105,000	105,000	-		-	Employee Stock Option (Right to Buy)
Toast Inc (Class A)	Aman Narang	Director, COO & Co-President	Sale of securities on an exchange or to another person at price $ 22.30 per share.	01 Feb 2023	104,469	1,861,840	-	22.3	2,329,659	Class A Common Stock
Alphatec Holdings Inc	Patrick S Miles	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	103,391	5,928,117 (9%)	0%		0	Common Stock
Monopar Therapeutics Inc	Kim R. Tsuchimoto	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	102,688	102,688	-		-	Stock Options
Monopar Therapeutics Inc	Andrew Cittadine	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	102,688	102,688	-		-	Stock Options
Robinhood Markets Inc (Class A)	Daniel M Gallagher	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	102,528	437,101	-		-	Class A Common Stock
Zentalis Pharma Inc High Gain High Volume	Melissa B. Epperly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	101,957	399,899	-		0	Common Stock
Owens Corning Dividend	Brian D. Chambers	Director, Chair, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	100,869	312,504 (0%)	0%		0	$.01 Par Value Common
ProPetro Holding Corp	Phillip Anthony Gobe	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.75 per share.	01 Feb 2023	100,152	268,492 (0%)	0%	9.8	976,482	Common Stock
Biocryst Pharma Inc	Jon P. Stonehouse	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	100,000	0	-		-	Emp. Stock Option (Right to Buy)
Biocryst Pharma Inc	Jon P. Stonehouse	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 10.38 per share.	01 Feb 2023	100,000	1,008,739 (0%)	0%	10.4	1,038,000	Common Stock
Biocryst Pharma Inc	Jon P. Stonehouse	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share.	01 Feb 2023	100,000	1,108,739 (0%)	0%	5.5	545,000	Common Stock
Lantronix Inc	Eric Bass	VP of Engineering		01 Feb 2023	100,000	100,000	-		-	Stock Options
Village Farms Intl Inc	Stephen C. Ruffini	Director, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	100,000	100,000	-		-	Options
Village Farms Intl Inc	Michael DeGiglio	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	100,000	100,000	-		-	Options
Alphatec Holdings Inc	David P. Sponsel	EVP, SALES	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	98,078	645,061 (1%)	0%		0	Common Stock
PulteGroup Results Board Meeting	Ryan R Marshall	Director, Chief Exec Officer, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	97,422	773,976 (0%)	0%		0	Common Stock
Sarcos Tech and Robotics Corp	Benjamin G. Wolff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	95,918	3,457,666	-		0	Common Stock
PulteGroup Results Board Meeting	Ryan R Marshall	Director, Chief Exec Officer, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	94,421	719,189 (0%)	0%		0	Common Stock
Ares Management Corp (Class A)	Antony P. Ressler	Director, Co-Founder & Exec. Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 85.13 per share.	01 Feb 2023	94,211	480,027 (0%)	0%	85.1	8,020,182	Class A Common Stock
PLBY Grp Inc	Lance Barton	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share.	01 Feb 2023	92,870	694,602	-	2.6	237,385	Common Stock
Alphatec Holdings Inc	Craig E. Hunsaker	EVP, PEOPLE/CULTURE & GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	92,349	1,449,820 (2%)	0%		0	Common Stock
Brixmor Property Grp Inc	James M. Taylor	President and CEO		01 Feb 2023	91,650	696,307 (0%)	0%		-	Common Stock
Brixmor Property Grp Inc	James M. Taylor	President and CEO		01 Feb 2023	91,648	91,648	-		-	Restricted Stock Units
Zentalis Pharma Inc High Gain High Volume	Kevin D. Bunker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	91,354	875,464	-		0	Common Stock
DTE Energy	Gerardo Norcia	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	90,865	352,276 (0%)	0%		0	Common Stock
Alphatec Holdings Inc	John Todd Koning	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	90,242	386,503 (0%)	0%		0	Common Stock
IBM Results Board Meeting	Arvind Krishna	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	88,602	342,904 (0%)	0%		0	Common Stock
ProPetro Holding Corp	Adam Munoz	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	87,179	209,783	-		-	Restricted Stock Units
Caredx Inc	Alexander L. Johnson	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	85,100	197,450 (0%)	0%		0	Common Stock
Caredx Inc	Abhishek Jain	Chief Financial Officer		01 Feb 2023	85,100	133,800 (0%)	0%		0	Common Stock
Caredx Inc	Abraham Ronai	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	85,100	160,839 (0%)	0%		0	Common Stock
Artelo Biosciences Inc	Gregory D. Gorgas	Director, Pres, CEO, CFO, Treas & Secr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	85,000	85,000	-		-	Stock Option (right to buy)
Lindblad Expeditions Holdings Inc	Sven-Olof Lindblad	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 12.26 per share.	01 Feb 2023	84,821	11,719,867 (23%)	0%	12.3	1,039,905	Common Stock
Carrier Global Dividend	Nadia Villeneuve	Senior VP & CHRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	84,655	84,655	-		-	Stock Appreciation Right
Carrier Global Dividend	Timothy N. White	President, Refrigeration		01 Feb 2023	84,015	84,015	-		-	Stock Appreciation Right
Arbutus Biopharma Corp	Michael J. McElhaugh	Chief Business Officer		01 Feb 2023	83,700	1,391,157 (2%)	0%		0	Common Shares
Robinhood Markets Inc (Class A)	Daniel M Gallagher	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	83,251	416,255	-		-	Restricted Stock Units
Arbutus Biopharma Corp	Michael J. Sofia	Chief Scientific Officer		01 Feb 2023	82,200	1,385,603 (2%)	0%		0	Common Shares
Western Union Co High Gain High Volume	Devin McGranahan	Director, CEO & President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.17 per share.	01 Feb 2023	81,704	290,568 (0%)	0%	14.2	1,157,746	Common Stock
Natural Resource Partners LP - Unit	Corbin J. Robertson	Director, Chairman and CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	81,657	81,657	-		-	Phantom Units
Arbutus Biopharma Corp	David C. Hastings	Chief Financial Officer		01 Feb 2023	79,000	79,000 (0%)	0%		0	Common Shares
Polaris Inc	Michael T. Speetzen	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	78,456	78,456	-		-	Employee Stock Options (right to buy)
Monopar Therapeutics Inc	Kim R. Tsuchimoto	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	78,234	135,382	-		-	Restricted Stock Units
Monopar Therapeutics Inc	Andrew Cittadine	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	78,234	126,984	-		-	Restricted Stock Units
Carrier Global Dividend	Kevin J. OConnor	Senior VP & CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	77,205	77,205	-		-	Stock Appreciation Right
Alphatec Holdings Inc	Scott Lish	SVP, DEVELOPMENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	76,638	399,980 (0%)	0%		0	Common Stock
PLBY Grp Inc	Bernhard Kohn	Director, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share.	01 Feb 2023	75,361	125,361	-	2.6	192,630	Common Stock
Design Therapeutics Inc	Julie Burgess	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	75,000	75,000	-		-	Stock Option (right to buy)
Freshworks Inc (Class A)	Rathna Girish Mathrubootham	Director, Chief Executive Officer		01 Feb 2023	73,782	0	-	17.0	1,251,343	Class A Common Stock
Freshworks Inc (Class A)	Rathna Girish Mathrubootham	Director, Chief Executive Officer		01 Feb 2023	73,782	16,314,209	-		-	Class B Common Stock
Freshworks Inc (Class A)	Rathna Girish Mathrubootham	Director, Chief Executive Officer		01 Feb 2023	73,782	73,782	-		0	Class A Common Stock
Taylor Morrison Home Corp Results Board Meeting	William H. Lyon	Director	Sale of securities on an exchange or to another person at price $ 36.24 per share.	01 Feb 2023	71,395	4,263,921 (3%)	0%	36.2	2,587,355	Common Stock
Consumer Portfolio Service Inc	Charles E. Bradley	Director, CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	70,001	0	-		-	Stock Option (right to buy)
Arbutus Biopharma Corp	Elizabeth Howard	EVP, GC, Compliance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	69,700	86,024 (0%)	0%		0	Common Shares
Shutterstock Inc	John Caine	GLOBAL HEAD OF ECOMMERCE	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	68,799	0	-		-	Restricted Stock Unit
Dutch Bros Inc (Class A)	Jonathan Ricci	CEO and President	Sale of securities on an exchange or to another person at price $ 36.67 per share.	01 Feb 2023	67,817	2,148,518	-	36.7	2,486,849	Class A Common Stock
Brixmor Property Grp Inc	James M. Taylor	President and CEO		01 Feb 2023	67,625	67,625	-		-	Restricted Stock Units
Workiva Inc (Class A)	Martin J. Vanderploeg	Director, CEO	Grant, award, or other acquisition of securities at price $ 92.79 per share.	01 Feb 2023	67,356	460,329 (1%)	0%	92.8	6,249,963	Class A Common Stock
Masco	Keith J. Allman	Director, President and CEO		01 Feb 2023	66,228	258,085 (0%)	0%	54.7	3,624,387	Common Stock
Masco	Keith J. Allman	Director, President and CEO		01 Feb 2023	66,228	56,853	-		-	Employee Stock Option
Masco	Keith J. Allman	Director, President and CEO		01 Feb 2023	66,228	324,313 (0%)	0%	19.7	1,302,314	Common Stock
ORIC Pharma Inc	Jacob M. Chacko	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	66,000	66,000	-		-	Restricted Stock Unit
Ginkgo Bioworks Holdings Inc (Class A)	Mark Dmytruk	See remarks		01 Feb 2023	65,284	1,626,890	-		-	Restricted Stock Units
Ginkgo Bioworks Holdings Inc (Class A)	Mark Dmytruk	See remarks		01 Feb 2023	65,284	519,833	-		-	Class A Common Stock
Reynolds Consumer Products Inc	V. Lance Mitchell	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	65,017	65,017	-		-	Restricted Stock Units
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	65,003	151,332 (0%)	0%		0	Common Stock
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	65,003	0	-		-	Restricted Stock Units
Alphatec Holdings Inc	John Todd Koning	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	64,806	451,309 (0%)	0%		0	Common Stock
LoanDepot Inc (Class A)	Jeff Walsh	President, LDI Mortgage		01 Feb 2023	63,126	4,414,289 (7%)	0%	2.6	162,007	Class A Common Stock, par value $0.001 per share
ProPetro Holding Corp	David S Schorlemer	Chief Financial Officer		01 Feb 2023	61,538	146,133	-		-	Restricted Stock Units
Alphatec Holdings Inc	David P. Sponsel	EVP, SALES	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	60,629	705,690 (1%)	0%		0	Common Stock
Aethlon Medical Inc 10-year low	D. Lee Arnold	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	60,620	60,620	-		-	Employee Stock Option (Right to Buy)
Lantronix Inc	Eric Bass	VP of Engineering		01 Feb 2023	59,267	59,267	-		-	Restricted Stock Units
Zentalis Pharma Inc High Gain High Volume	Andrea Paul	General Counsel		01 Feb 2023	59,217	59,217	-		-	Stock Option (Right to Buy)
Apartment Investment & Management Co. (Class A)	Deborah Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	58,480	170,323	-		-	Stock Option (right to buy)
GE HealthCare Tech Partnership	Taha Kass-Hout	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	58,005	58,005	-		-	Employee Stock Option (right to buy)
Robinhood Markets Inc (Class A)	Vladimir Tenev	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	57,633	1,302,236	-		-	Class A Common Stock
Robinhood Markets Inc (Class A)	Vladimir Tenev	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	57,633	11,411,259	-		-	Market-Based Performance Stock Units
Robinhood Markets Inc (Class A)	Baiju Bhatt	Director, Chief Creative Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	57,633	11,411,259	-		-	Market-Based Performance Stock Units
Robinhood Markets Inc (Class A)	Baiju Bhatt	Director, Chief Creative Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	57,633	85,899	-		-	Class A Common Stock
Southwest Airlines Results Board Meeting	Robert E. Jordan	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	57,606	231,266 (0%)	0%		0	Common Stock
Lindblad Expeditions Holdings Inc	Sven-Olof Lindblad	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 12.07 per share.	01 Feb 2023	57,425	11,804,688 (23%)	0%	12.1	693,120	Common Stock
Workiva Inc (Class A)	Julie Iskow	Director, President & COO		01 Feb 2023	56,579	207,375 (0%)	0%	92.8	5,249,965	Class A Common Stock
Rhythm Pharma Inc	David P. Meeker	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	56,500	56,500	-		-	Restricted Stock Units
Dutch Bros Inc (Class A)	Jonathan Ricci	CEO and President	Sale of securities on an exchange or to another person at price $ 38.57 per share.	01 Feb 2023	56,366	2,056,335	-	38.6	2,174,037	Class A Common Stock
Amplify Energy Corp	Martyn Willsher	PRESIDENT, CEO		01 Feb 2023	56,117	137,611	-		-	Restricted Stock Units
Amplify Energy Corp	Martyn Willsher	PRESIDENT, CEO		01 Feb 2023	56,117	147,286	-		-	Performance Stock Units
Black Stone Minerals L.P. - Unit	Steve Putman	SVP, GC, and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	55,711	544,431 (0%)	0%		0	Common units representing limited partner interests
Carlyle Grp Inc	Chas Andrews	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	55,618	91,414 (0%)	0%		0	Common Stock
Bluejay Diagnostics Inc	Neil Dey	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share.	01 Feb 2023	55,612	550,538	-	0.4	24,469	Common Stock
United Parcel Service (Class B)	Kathleen M. Gutmann	Pres Intl, Healthcare and SCS	Other type of transaction at price $ 0.00 per share.	01 Feb 2023	55,574	46,687 (0%)	0%		0	Class A Common Stock
United Parcel Service (Class B)	Kathleen M. Gutmann	Pres Intl, Healthcare and SCS	Other type of transaction at price $ 0.00 per share.	01 Feb 2023	55,574	55,574 (0%)	0%		0	Class B Common Stock
GE HealthCare Tech Partnership	Frank R. Jimenez	GC & Corporate Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	54,870	54,870	-		-	Employee Stock Option (right to buy)
Village Farms Intl Inc	Michael DeGiglio	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.11 per share.	01 Feb 2023	54,212	9,313,741 (17%)	0%	1.1	60,240	Common shares
Rhythm Pharma Inc	Hunter C. Smith	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	53,600	53,600	-		-	Stock Option (Right to Buy)
Southwest Airlines Results Board Meeting	Gary C. Kelly	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	53,326	198,778 (0%)	0%		0	Common Stock
LoanDepot Inc (Class A)	Jeff Walsh	President, LDI Mortgage		01 Feb 2023	53,289	13,159,832	-		-	Common Units
LoanDepot Inc (Class A)	Jeff Walsh	President, LDI Mortgage		01 Feb 2023	53,289	4,477,415 (7%)	0%		0	Class A Common Stock, par value $0.001 per share
Consumer Portfolio Service Inc	Charles E. Bradley	Director, CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.86 per share.	01 Feb 2023	53,255	3,510,012 (15%)	0%	6.9	365,329	Common Stock, no par value
C3.ai Inc (Class A)	Thomas M. Siebel	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	53,125	1,809,515	-		-	Class A Common Stock
C3.ai Inc (Class A)	Thomas M. Siebel	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	53,125	690,625	-		-	Restricted Stock Units
Advanced Emissions Soln Inc	Richard M. Campbell-Breeden	Director	Purchase of securities on an exchange or from another person at price $ 4.00 per share.	01 Feb 2023	52,742	52,742 (0%)	0%	4	210,968	Common Stock
Alphatec Holdings Inc	Scott Lish	SVP, DEVELOPMENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	50,083	450,063 (0%)	0%		0	Common Stock
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	750,000	-		-	Employee Stock Option (Right to Buy)
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	800,000	-		-	Employee Stock Option (Right to Buy)
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	850,000	-		-	Employee Stock Option (Right to Buy)
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	622,518 (0%)	0%	47.1	2,355,240	Common Shares
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	672,518 (0%)	0%	19.4	967,500	Common Shares
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	622,518 (0%)	0%	47.6	2,380,125	Common Shares
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	672,518 (0%)	0%	19.4	967,500	Common Shares
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	672,518 (0%)	0%	19.4	967,500	Common Shares
Genpact Ltd	N. V. Tyagarajan	Director, President and CEO		01 Feb 2023	50,000	622,518 (0%)	0%	47.4	2,370,940	Common Shares
Energy Vault Holdings Inc	Andrea Pedretti	Chief Technology Officer		01 Feb 2023	50,000	1,302,887	-	4.4	219,315	Common Stock
Consumer Portfolio Service Inc	Brian J. Rayhill	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	50,000	0	-		-	Stock Option (right to buy)
PLBY Grp Inc	Bernhard Kohn	Director, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	50,000	0	-		-	Subscription Right
GE HealthCare Tech Partnership	Taha Kass-Hout	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	49,539	56,145	-		0	Common Stock, par value $0.01 per share
Strata Critical Medical Inc (Class A)	William A. Heyburn	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share.	01 Feb 2023	49,451	1,498,723	-	0.2	8,901	Class A common stock, $0.0001 par value per share
Strata Critical Medical Inc (Class A)	William A. Heyburn	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	49,451	0	-		-	Stock Option (right to buy)
IBM Results Board Meeting	Arvind Krishna	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	48,724	254,302 (0%)	0%		0	Common Stock
Rambus Inc	Luc Seraphin	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	47,915	256,224 (0%)	0%		0	Common Stock
Eli Lilly Acquisition	David A. Ricks	Director, President, Chair, and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	47,786	413,102 (0%)	0%		0	Common Stock
Eli Lilly Acquisition	David A. Ricks	Director, President, Chair, and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	47,786	0	-		-	Restricted Stock Unit
GE HealthCare Tech Partnership	Helmut Zodl	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	47,031	47,031	-		-	Employee Stock Option (right to buy)
Rhythm Pharma Inc	Jennifer Chien	EVP, Head of North America	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	46,900	46,900	-		-	Stock Option (Right to Buy)
Brixmor Property Grp Inc	James M. Taylor	President and CEO		01 Feb 2023	46,787	649,520 (0%)	0%	23.7	1,106,980	Common Stock
Alphatec Holdings Inc	Craig E. Hunsaker	EVP, PEOPLE/CULTURE & GC	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	46,175	1,495,995 (2%)	0%		0	Common Stock
Owens Corning Dividend	Brian D. Chambers	Director, Chair, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.97 per share.	01 Feb 2023	45,745	266,759 (0%)	0%	103.0	4,710,363	$.01 Par Value Common
Business First Bancshares Inc Results Board Meeting	David R. Melville	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 20.74 per share.	01 Feb 2023	45,570	227,709 (1%)	0%	20.7	945,122	COMMON STOCK
Carrier Global Dividend	Kyle Crockett	Vice President, Controller		01 Feb 2023	45,415	45,415	-		-	Stock Appreciation Right
Village Farms Intl Inc	Michael DeGiglio	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.17 per share.	01 Feb 2023	44,386	9,358,127 (17%)	0%	1.2	51,834	Common shares
Natural Resource Partners LP - Unit	Craig W. Nunez	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	44,379	44,379	-		-	Phantom Units
Hormel Foods	James P. Snee	Director, CHAIRMAN, PRESIDENT AND CEO		01 Feb 2023	44,112	276,803 (0%)	0%		0	Common Stock
Caredx Inc	Alexander L. Johnson	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	44,100	44,100	-		-	Stock Option (right to buy)
Caredx Inc	Abhishek Jain	Chief Financial Officer		01 Feb 2023	44,100	44,100	-		-	Stock Option (right to buy)
Caredx Inc	Abraham Ronai	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	44,100	44,100	-		-	Stock Option (right to buy)
IBM Results Board Meeting	Arvind Krishna	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.30 per share.	01 Feb 2023	43,894	275,968 (0%)	0%	134.3	5,894,745	Common Stock
Transocean Ltd	David A. Tonnel	SVP - CHIEF ACCOUNTING OFFICER	Sale of securities on an exchange or to another person at price $ 6.94 per share.	01 Feb 2023	43,668	233,399 (0%)	0%	6.9	303,056	Registered Shares
FirstCash Holdings Inc Results	Rick L. Wessel	Director, Vice-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	43,202	862,287 (2%)	0%		0	Common Stock
GE HealthCare Tech Partnership	Jan Makela	CEO, Imaging	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	43,112	43,112	-		-	Employee Stock Option (right to buy)
ProPetro Holding Corp	Adam Munoz	President and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	42,927	48,408 (0%)	0%		0	Common Stock
PulteGroup Results Board Meeting	Ryan R Marshall	Director, Chief Exec Officer, President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.36 per share.	01 Feb 2023	42,635	676,554 (0%)	0%	57.4	2,445,544	Common Stock
Diodes Inc	Keh-Shew Lu	Director, President & CEO		01 Feb 2023	42,000	284,584 (0%)	0%		0	Diodes Incorporated Common Stock - Performance Stock Units
Diodes Inc	Keh-Shew Lu	Director, President & CEO		01 Feb 2023	42,000	108,188 (0%)	0%		0	Diodes Incorporated Common Stock
Rhythm Pharma Inc	Yann Mazabraud	EVP, Head of International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	41,500	41,500	-		-	Restricted Stock Units
Zentalis Pharma Inc High Gain High Volume	Andrea Paul	General Counsel		01 Feb 2023	40,783	40,783	-		0	Common Stock
Progress Software Corp	Anthony Folger	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	40,456	0	-		-	Restricted Stock Units
Progress Software Corp	Anthony Folger	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	40,456	45,059 (0%)	0%		0	Common Stock
908 Devices Inc	Kevin J. Knopp	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 10.51 per share.	01 Feb 2023	40,000	447,848	-	10.5	420,400	Common Stock
Moderna	Stephane Bancel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	40,000	1,627,155	-		-	Stock Option (Right to Buy)
Moderna	Stephane Bancel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	40,000	1,667,155	-		-	Stock Option (Right to Buy)
Moderna	Stephane Bancel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share.	01 Feb 2023	40,000	5,451,946 (1%)	0%	1.0	39,600	Common Stock
Moderna	Stephane Bancel	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share.	01 Feb 2023	40,000	5,451,946 (1%)	0%	1.0	39,600	Common Stock
Black Stone Minerals L.P. - Unit	Carrie P. Clark	SVP, Land and Legal		01 Feb 2023	39,325	84,313 (0%)	0%		0	Common units representing limited partner interests
Bluejay Diagnostics Inc	Kenneth R. Fisher	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share.	01 Feb 2023	39,316	113,184	-	0.4	17,299	Common Stock
GE HealthCare Tech Partnership	Betty D. Larson	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	39,193	39,193	-		-	Employee Stock Option (right to buy)
Orasure Tech Inc	Kathleen Gallagher Weber	Chief Product Officer		01 Feb 2023	39,016	238,218 (0%)	0%	5.4	212,442	Common Stock
FirstCash Holdings Inc Results	Rick L. Wessel	Director, Vice-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	38,174	883,462 (2%)	0%		0	Common Stock
Robinhood Markets Inc (Class A)	Daniel M Gallagher	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.78 per share.	01 Feb 2023	38,166	398,935	-	10.8	411,429	Class A Common Stock
Apartment Investment & Management Co. (Class A)	H. Lynn C. Stanfield	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	37,678	350,211	-		-	Class A Common Stock
Annaly Cap Management Inc Results Board Meeting	Anthony C. Green	Chief Corporate Officer, CLO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	37,109	131,753 (0%)	0%		0	Common Stock
Annaly Cap Management Inc Results Board Meeting	Serena Wolfe	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	37,109	58,966 (0%)	0%		0	Common Stock
HCA Healthcare	William B. Rutherford	CFO and EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	37,000	0	-		-	Stock Appreciation Right
HCA Healthcare	William B. Rutherford	CFO and EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share.	01 Feb 2023	37,000	119,527 (0%)	0%	69.0	2,551,520	Common Stock
Dutch Bros Inc (Class A)	Jonathan Ricci	CEO and President	Sale of securities on an exchange or to another person at price $ 37.51 per share.	01 Feb 2023	35,817	2,112,701	-	37.5	1,343,496	Class A Common Stock
ProPetro Holding Corp	Samuel D. Sledge	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	35,704	73,145 (0%)	0%		0	Common Stock
Corporate Office Properties Trust	Anthony Mifsud	EVP AND CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	35,606	126,872	-		-	Profit Interest Units
Waste Management	James C. Fish	Pres, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 152.11 per share.	01 Feb 2023	35,463	180,648 (0%)	0%	152.1	5,394,100	Common Stock
PulteGroup Results Board Meeting	John James Chadwick	Exec VP & Chief Operating Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	35,392	123,875 (0%)	0%		0	Common Stock
Neoleukin Therapeutics Inc	Priti Patel	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	35,000	35,000	-		-	Restricted Stock Units
Neoleukin Therapeutics Inc	Priti Patel	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	35,000	45,462 (0%)	0%		0	Common Stock
HCA Healthcare	William B. Rutherford	CFO and EVP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 261.46 per share.	01 Feb 2023	34,895	111,632 (0%)	0%	261.5	9,123,647	Common Stock
Vertex Pharma	Jeffrey M Leiden	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	34,890	68,775 (0%)	0%		0	Common Stock
ProPetro Holding Corp	John J. Mitchell	Gen. Counsel & Corp. Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	34,564	49,253	-		-	Restricted Stock Units
Rambus Inc	Sean Fan	COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	34,554	149,569 (0%)	0%		0	Common Stock
Nerdy Inc (Class A)	Heidi Robinson	Chief Product Officer	Sale of securities on an exchange or to another person at price $ 3.01 per share.	01 Feb 2023	34,401	1,177,649	-	3.0	103,719	Class A Common Stock
Nerdy Inc (Class A)	Heidi Robinson	Chief Product Officer	Sale of securities on an exchange or to another person at price $ 3.06 per share.	01 Feb 2023	33,946	1,143,703	-	3.1	103,739	Class A Common Stock
Brixmor Property Grp Inc	Angela M. Aman	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	33,604	33,604	-		-	Restricted Stock Units
Brixmor Property Grp Inc	Angela M. Aman	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	33,604	190,337 (0%)	0%		-	Common Stock
Rambus Inc	Luc Seraphin	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.41 per share.	01 Feb 2023	33,562	208,309 (0%)	0%	43.4	1,456,926	Common Stock
C3.ai Inc (Class A)	Thomas M. Siebel	Director, Chief Executive Officer, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	01 Feb 2023	33,500	3,583,894	-		0	Class A Common Stock
C3.ai Inc (Class A)	Thomas M. Siebel	Director, Chief Executive Officer, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	01 Feb 2023	33,500	1,756,390	-		0	Class A Common Stock
Rhythm Pharma Inc	Joseph Shulman	Chief Technical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	33,500	33,500	-		-	Stock Option (Right to Buy)
Frequency Therapeutics Inc	David L. Lucchino	Director, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	01 Feb 2023	33,345	423,421 (1%)	0%		0	Common Stock
Apollo Global (Class A) (New)	John J. Suydam	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 72.00 per share.	01 Feb 2023	33,334	277,076 (0%)	0%	72	2,400,048	Common Stock
Kirby Corp	David W. Grzebinski	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	32,860	32,860	-		-	Restricted Stock Units
DTE Energy	Gerardo Norcia	Director, Chairman, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.17 per share.	01 Feb 2023	32,763	319,513 (0%)	0%	116.2	3,806,045	Common Stock
Etsy Inc Analyst Downgrade	Rachana Kumar	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	32,590	32,590	-		-	Restricted Stock Units
Alphatec Holdings Inc	John Todd Koning	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	32,403	483,712 (0%)	0%		0	Common Stock
Enovix Corp	Harrold Rust	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.20 per share.	01 Feb 2023	32,104	60,963	-	8.2	263,253	Common Stock
Brixmor Property Grp Inc	Mark T. Horgan	EVP, Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	32,078	245,517 (0%)	0%		-	Common Stock
Brixmor Property Grp Inc	Mark T. Horgan	EVP, Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	32,076	32,076	-		-	Restricted Stock Units
IBM Results Board Meeting	James J. Kavanaugh	Sr. VP and CFO	Sale of securities on an exchange or to another person at price $ 133.61 per share.	01 Feb 2023	31,949	81,037 (0%)	0%	133.6	4,268,674	Common Stock
Carrier Global Dividend	Ajay Agrawal	Senior VP, Strategy & Services	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	31,790	31,790	-		-	Stock Appreciation Right
Vertex Pharma	Jeffrey M Leiden	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	31,462	33,885 (0%)	0%		0	Common Stock
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.94 per share.	01 Feb 2023	31,430	119,902 (0%)	0%	53.9	1,695,334	Common Stock
Southwest Airlines Results Board Meeting	Andrew Watterson	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	31,322	85,648 (0%)	0%		0	Common Stock
Commerce Bancshares Inc	John Kemper	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	31,274	192,077 (0%)	0%		0	Common Stock
Workiva Inc (Class A)	Jill E. Klindt	SVP, CFO, CAO & Treasurer		01 Feb 2023	30,930	107,187 (0%)	0%	92.8	2,869,995	Class A Common Stock
Agilon Health Inc	Benjamin Kornitzer	Chief Med. & Quality Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	30,782	191,351	-		-	Options (Rights to Buy)
Agilon Health Inc	Benjamin Kornitzer	Chief Med. & Quality Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.99 per share.	01 Feb 2023	30,782	41,208	-	9.0	276,730	Common Stock
Agilon Health Inc	Benjamin Kornitzer	Chief Med. & Quality Officer	Sale of securities on an exchange or to another person at price $ 22.99 per share.	01 Feb 2023	30,782	10,426	-	23.0	707,561	Common Stock
Block Inc (Class A)	Alyssa Henry	Square Lead		01 Feb 2023	30,769	449,436 (0%)	0%		0	Class A Common Stock
Block Inc (Class A)	Alyssa Henry	Square Lead		01 Feb 2023	30,769	0	-		-	Class B Common Stock
Block Inc (Class A)	Alyssa Henry	Square Lead	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	30,769	30,769	-		-	Class B Common Stock
Block Inc (Class A)	Alyssa Henry	Square Lead	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	30,769	399,997	-		-	Stock Option (right to buy)
Brixmor Property Grp Inc	Brian T. Finnegan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,550	30,550	-		-	Restricted Stock Units
Brixmor Property Grp Inc	Brian T. Finnegan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,550	208,722 (0%)	0%		-	Common Stock
ServiceNow Results Board Meeting	William R. Mcdermott	Director, Chairman & CEO	Sale of securities on an exchange or to another person at price $ 459.14 per share.	01 Feb 2023	30,500	11,518 (0%)	0%	459.1	14,003,825	Common Stock
Alphatec Holdings Inc	David P. Sponsel	EVP, SALES	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,314	736,004 (1%)	0%		0	Common Stock
Piedmont Office Realty Trust Inc (Class A)	Christopher Brent Smith	Director, President & Chief Exec. Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,223	247,332 (0%)	0%		0	Common Stock
Atkore Inc	William E. Waltz	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	30,000	79,600	-		-	Stock Options (right to buy)
Atkore Inc	William E. Waltz	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 140.26 per share.	01 Feb 2023	30,000	70,080 (0%)	0%	140.3	4,207,875	Common Stock
Atkore Inc	William E. Waltz	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.12 per share.	01 Feb 2023	30,000	100,080 (0%)	0%	9.1	273,600	Common Stock
HCA Healthcare	William B. Rutherford	CFO and EVP	Sale of securities on an exchange or to another person at price $ 258.19 per share.	01 Feb 2023	30,000	81,632 (0%)	0%	258.2	7,745,568	Common Stock
MGM Resorts International	Corey Ian Sanders	CHIEF OPERATING OFFICER	Sale of securities on an exchange or to another person at price $ 42.00 per share.	01 Feb 2023	30,000	201,498 (0%)	0%	42	1,260,000	Common Stock $.01 Par Value ND
Aclaris Therapeutics Inc	Gail Cawkwell	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,000	30,000	-		-	Restricted Stock Units
Aclaris Therapeutics Inc	James Loerop	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,000	30,000	-		-	Restricted Stock Units
Aclaris Therapeutics Inc	Joseph Monahan	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,000	30,000	-		-	Restricted Stock Units
Aclaris Therapeutics Inc	Kevin Balthaser	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	30,000	30,000	-		-	Restricted Stock Units
Outset Medical Inc	Leslie L. Trigg	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share.	01 Feb 2023	30,000	444,044	-	3.9	116,400	Common Stock
Outset Medical Inc	Leslie L. Trigg	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	30,000	40,508	-		-	Performance Options (right to buy)
Outset Medical Inc	Leslie L. Trigg	Director, Chair and CEO	Sale of securities on an exchange or to another person at price $ 28.06 per share.	01 Feb 2023	30,000	414,044	-	28.1	841,779	Common Stock
Red Cat Holdings Inc	Joseph P. Hernon	CFO	Grant, award, or other acquisition of securities at price $ 1.21 per share.	01 Feb 2023	30,000	424,155	-	1.2	36,300	Common Stock
Zentalis Pharma Inc High Gain High Volume	Kevin D. Bunker	Chief Scientific Officer	Gift of securities by or to the insider at price $ 0.00 per share.	01 Feb 2023	30,000	784,110	-		0	Common Stock
Franklin Resources Inc	Alok Sethi	EVP, Technology and Operations		01 Feb 2023	29,503	92,132 (0%)	0%	31.1	917,325	Common Stock, par value $.10
Amplify Energy Corp	Eric M. Willis	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,462	78,359	-		-	Restricted Stock Units
Amplify Energy Corp	Eric M. Willis	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,462	84,163	-		-	Performance Stock Units
Amplify Energy Corp	Jason McGlynn	SVP, CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,462	99,785	-		-	Performance Stock Units
Amplify Energy Corp	Jason McGlynn	SVP, CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,462	78,311	-		-	Restricted Stock Units
Commerce Bancshares Inc	John Kemper	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,184	29,184	-		-	Stock Appreciation Rights
Vertex Pharma	Reshma Kewalramani	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	29,118	131,104 (0%)	0%		0	Common Stock
MongoDB Inc (Class A)	Dev C. Ittycheria	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	28,614	628,036	-		-	Employee Stock Option (Right to Buy)
MongoDB Inc (Class A)	Dev C. Ittycheria	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share.	01 Feb 2023	28,614	225,264 (0%)	0%	6.5	185,991	Class A Common Stock
Owens Corning Dividend	Brian D. Chambers	Director, Chair, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	28,251	211,635 (0%)	0%		0	$.01 Par Value Common
Southwest Airlines Results Board Meeting	Linda B. Rutherford	Chief Admin & Comm. Officer		01 Feb 2023	28,067	64,691 (0%)	0%		0	Common Stock
Seagate Tech	Jeffrey D. Nygaard	EVP, Operations and Technology	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	28,000	12,301	-		-	NQ Options
Seagate Tech	Jeffrey D. Nygaard	EVP, Operations and Technology	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.85 per share.	01 Feb 2023	28,000	58,360 (0%)	0%	39.9	1,115,800	Ordinary Shares
Ginkgo Bioworks Holdings Inc (Class A)	Mark Dmytruk	See remarks		01 Feb 2023	27,889	493,582	-	2.1	59,933	Class A Common Stock
Vistance Networks Inc	Markus R. Ogurek	SVP & President, NICS	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.60 per share.	01 Feb 2023	27,852	152,448 (0%)	0%	8.6	239,527	Common Stock
Southwest Airlines Results Board Meeting	Tammy Romo	EVP & CFO		01 Feb 2023	27,718	201,822 (0%)	0%		0	Common Stock
Apartment Investment & Management Co. (Class A)	Jennifer Johnson	EVP, CAO, and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	27,704	240,235	-		-	Class A Common Stock
Polaris Inc	Kenneth J. Pucel	EVP, Global Ops & CTO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	27,549	27,549	-		-	Employee Stock Options (right to buy)
Bluejay Diagnostics Inc	Donald R. Chase	Director	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	27,500	792,852	-	0.4	12,100	Common Stock
Bluejay Diagnostics Inc	Fred S. Zeidman	Director	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	27,500	27,500	-	0.4	12,100	Common Stock
Bluejay Diagnostics Inc	Gary G. Gemignani	Director		01 Feb 2023	27,500	27,500	-	0.4	12,100	Common Stock
Bluejay Diagnostics Inc	Douglas C. Wurth	Director	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	27,500	2,313,849	-	0.4	12,100	Common Stock
Bluejay Diagnostics Inc	Svetlana Dey	Director	Grant, award, or other acquisition of securities at price $ 0.44 per share.	01 Feb 2023	27,500	37,500	-	0.4	12,100	Common Stock
IBM Results Board Meeting	James J. Kavanaugh	Sr. VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	27,463	101,930 (0%)	0%		0	Common Stock
Brixmor Property Grp Inc	Angela M. Aman	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	27,050	27,050	-		-	Restricted Stock Units
HCA Healthcare	William B. Rutherford	CFO and EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	27,000	19,100	-		-	Stock Appreciation Right
HCA Healthcare	William B. Rutherford	CFO and EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share.	01 Feb 2023	27,000	146,527 (0%)	0%	69.6	1,878,660	Common Stock
Vertex Pharma	Reshma Kewalramani	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,972	158,076 (0%)	0%		0	Common Stock
Rhythm Pharma Inc	Pamela J. Cramer	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,800	26,800	-		-	Stock Option (Right to Buy)
Brixmor Property Grp Inc	Steven F. Siegel	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,732	26,732	-		-	Restricted Stock Units
Brixmor Property Grp Inc	Steven F. Siegel	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,728	335,331 (0%)	0%		-	Common Stock
Apartment Investment & Management Co. (Class A)	R. Dary Stone	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,596	89,185	-		-	Class A Common Stock
Apartment Investment & Management Co. (Class A)	Jay Paul Leupp	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,596	100,596	-		-	Class A Common Stock
Apartment Investment & Management Co. (Class A)	Patricia L. Gibson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	26,596	98,451	-		-	Class A Common Stock
Block Inc (Class A)	Alyssa Henry	Square Lead	Sale of securities on an exchange or to another person at price $ 81.51 per share.	01 Feb 2023	26,418	423,018 (0%)	0%	81.5	2,153,331	Class A Common Stock
Southwest Airlines Results Board Meeting	Mark R. Shaw	EVP, CL&R Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	25,900	103,403 (0%)	0%		0	Common Stock
DT Midstream Inc	David Slater	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	25,680	25,680	-		-	Restricted Stock Units
Workiva Inc (Class A)	Brandon Ziegler	EVP, CLO, CAO & Secretary, Secretary	Grant, award, or other acquisition of securities at price $ 92.79 per share.	01 Feb 2023	25,649	113,905 (0%)	0%	92.8	2,379,971	Class A Common Stock
Research Soln Inc	Scott Ahlberg	Chief Operating Officer		01 Feb 2023	25,600	616,539	-	1.2	29,440	Common Stock
Research Soln Inc	Scott Ahlberg	Chief Operating Officer		01 Feb 2023	25,600	0	-		-	Options (right to buy)
Waste Management	John J. Morris	EVP & Chief Operation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 152.10 per share.	01 Feb 2023	25,471	120,932 (0%)	0%	152.1	3,874,266	Common Stock
Ares Management Corp (Class A)	Antony P. Ressler	Director, Co-Founder & Exec. Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 85.19 per share.	01 Feb 2023	25,269	712,670 (0%)	0%	85.2	2,152,666	Class A Common Stock
Brandywine Realty Trust Results Board Meeting	H. Jeffrey Devuono	EVP & Senior Managing Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.47 per share.	01 Feb 2023	25,046	294,528 (0%)	0%	6.5	162,048	Common Shares of Beneficial Interest
Alphatec Holdings Inc	Scott Lish	SVP, DEVELOPMENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	25,041	475,104 (0%)	0%		0	Common Stock
Aclaris Therapeutics Inc	Neal Walker	Director	Sale of securities on an exchange or to another person at price $ 16.75 per share.	01 Feb 2023	25,000	1,180,763 (2%)	0%	16.7	418,675	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Feb 01, 2023

Monitor US insider transactions and discover insider buying and selling of stocks on Feb 01, 2023.

The latest disclosure under SEC insider trading regulations was reported by PLBY Group Inc., where the revocation of 11,021,569 Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on Feb. 1, 2023.

Screeners based on Insider Trading parameters